ProCE Banner Activity

ExpressPoints
Expanding the Spectrum of HER2 Positivity for Precision Breast Cancer Care: Clinical Implications of HER2-Low Status

Slideset Download
Download this short summary slideset of key takeaways from a live satellite symposium on new developments in precision care for advanced HER2-low breast cancer.

Released: December 16, 2022

Expiration: December 15, 2023

No longer available for credit.
Begin Activity

Share

Faculty

Nadia Harbeck

Nadia Harbeck, MD, PhD

Full Professor
Director
Breast Center, LMU University Hospital
Ludwig-Maximilians University
Munich, Germany

Komal Jhaveri

Komal Jhaveri, MD, FACP

Associate Attending
Breast Medicine Service and Early Drug Development Service
Section Head, Endocrine Therapy Research Program
Clinical Director, Early Drug Development Service
Department of Medicine
Associate Professor of Medicine
Weill Cornell Medical College
New York, New York

Heather McArthur

Heather McArthur, MD, MPH

Associate Professor
Department of Internal Medicine
Clinical Director, Breast Cancer Program
Komen Distinguished Chair in Clinical Breast Cancer Research
UT Southwestern Medical Center
Dallas, Texas

Provided by

Provided by Clinical Care Options, LLC.
ProCE Banner

Supporters

AstraZeneca Pharmaceuticals

Daiichi Sankyo, Inc.

Faculty Disclosure

Primary Author

Nadia Harbeck, MD, PhD

Full Professor
Director
Breast Center, LMU University Hospital
Ludwig-Maximilians University
Munich, Germany

Komal Jhaveri, MD, FACP

Associate Attending
Breast Medicine Service and Early Drug Development Service
Section Head, Endocrine Therapy Research Program
Clinical Director, Early Drug Development Service
Department of Medicine
Associate Professor of Medicine
Weill Cornell Medical College
New York, New York

Heather McArthur, MD, MPH

Associate Professor
Department of Internal Medicine
Clinical Director, Breast Cancer Program
Komen Distinguished Chair in Clinical Breast Cancer Research
UT Southwestern Medical Center
Dallas, Texas